These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 16099010)

  • 1. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
    Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.
    Petit CM; Chouljenko VN; Iyer A; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2007 Apr; 360(2):264-74. PubMed ID: 17134730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.
    Broer R; Boson B; Spaan W; Cosset FL; Corver J
    J Virol; 2006 Feb; 80(3):1302-10. PubMed ID: 16415007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region.
    Follis KE; York J; Nunberg JH
    Virology; 2005 Oct; 341(1):122-9. PubMed ID: 16081124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry.
    Corver J; Broer R; van Kasteren P; Spaan W
    Virol J; 2009 Dec; 6():230. PubMed ID: 20034394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.
    Howard MW; Travanty EA; Jeffers SA; Smith MK; Wennier ST; Thackray LB; Holmes KV
    J Virol; 2008 Mar; 82(6):2883-94. PubMed ID: 18199653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    J Virol; 2005 Jun; 79(11):7195-206. PubMed ID: 15890958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage.
    Millet JK; Kien F; Cheung CY; Siu YL; Chan WL; Li H; Leung HL; Jaume M; Bruzzone R; Peiris JS; Altmeyer RM; Nal B
    PLoS One; 2012; 7(11):e49566. PubMed ID: 23185364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of SARS-CoV spike protein Trp-rich region in viral infectivity.
    Lu Y; Neo TL; Liu DX; Tam JP
    Biochem Biophys Res Commun; 2008 Jul; 371(3):356-60. PubMed ID: 18424264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
    McBride CE; Machamer CE
    J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
    Yi CE; Ba L; Zhang L; Ho DD; Chen Z
    J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein.
    Chang KW; Sheng Y; Gombold JL
    Virology; 2000 Mar; 269(1):212-24. PubMed ID: 10725213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.
    Belouzard S; Madu I; Whittaker GR
    J Biol Chem; 2010 Jul; 285(30):22758-63. PubMed ID: 20507992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.
    Madu IG; Roth SL; Belouzard S; Whittaker GR
    J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.
    Follis KE; York J; Nunberg JH
    Virology; 2006 Jul; 350(2):358-69. PubMed ID: 16519916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion.
    Madu IG; Belouzard S; Whittaker GR
    Virology; 2009 Oct; 393(2):265-71. PubMed ID: 19717178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
    Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
    J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.